Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sorafenib in Metastatic Papillary Thyroid Carcinoma with BRAF K601E Mutation on Liquid Biopsy: A Case Report and Literature Review.

Medicina (Kaunas, Lithuania) - 17 May 2022

Caterino Marianna, Pirozzi Mario, Facchini Sergio, Zotta Alessia, Sica Antonello, Lo Giudice Giorgio, Rauso Raffaele, Varriale Elisa, Ciardiello Fortunato, Fasano Morena

Abstract excerpt

Differentiated thyroid cancer (DTC) includes papillary and follicular carcinomas and is the most common type of thyroid cancer. The incidence of this cancer has increased in the last few years, and even if its prognosis is generally good for a subset of patients that does not respond to radioactive iodine (RAI) therapy, the prognosis is much worse: the median overall survival (OS) from discovery of metastasis is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Iodine Radioisotopes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Neoplasms

Share to Liquid Biopsy

Share to Quality of Life

Share to Sorafenib

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 35630083
DOI: 10.3390/medicina58050666
PMCID: PMC9144761

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sorafenib in Metastatic Papillary Thyroid Carcinoma with BRAF K601E Mutation on Liquid Biopsy: A Case Report and Literature Review.PMID 35630083Read ↗

(Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challenges.Semantic proximity Read ↗

Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre.Semantic proximity Read ↗

Metastatic papillary thyroid carcinoma in pleural effusion: a case report and review of the literature.Semantic proximity Read ↗

Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement.Semantic proximity Read ↗

BRAF V600E in thyroid cancer: navigating prognostic uncertainty and therapeutic opportunity.Semantic proximity Read ↗

Primary squamous cell carcinoma of thyroid with a novel BRAF mutation and High PDL-1 expression: A case report with treatment implications and review of literature.Semantic proximity Read ↗

Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.Semantic proximity Read ↗

Unveiling a rare BRAF mutation in minimally invasive follicular thyroid carcinoma: A case report.Semantic proximity Read ↗

New Perspectives Regarding Anaplastic Thyroid Carcinoma Approach Improvement.Semantic proximity Read ↗

Pancreatic metastasis arising from a BRAF(V600E)-positive papillary thyroid cancer: the role of endoscopic ultrasound-guided biopsy and response to sorafenib therapy.Semantic proximity Read ↗

Surgical perspective of T1799A BRAF mutation diagnostic value in papillary thyroid carcinoma.Semantic proximity Read ↗

Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.